| JNK-9L |
ENSG00000031544.10 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000104691.10 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000125804.9 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000132832.5 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000145063.10 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000153363.8 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000163597.10 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000174171.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000175061.13 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000175699.8 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000175701.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000177337.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000177410.8 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000177757.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000177822.3 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000180279.5 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000180712.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000182310.8 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000182873.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000184068.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000184068.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000184274.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000185186.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000186056.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000186594.8 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000188206.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000188660.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000189419.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000196421.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000196696.8 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000196756.7 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000196951.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000196960.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000197989.9 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000203321.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000203325.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000203496.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000203875.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000203999.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000204055.4 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000204241.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000204380.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000204588.5 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000204791.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000204792.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000204802.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000204802.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000204929.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000205037.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000205054.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000205054.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000205293.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000205500.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000205662.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000206176.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000206417.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000206567.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000212163.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000212163.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000212163.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000212552.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000213742.2 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000213981.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000213994.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000214347.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000214407.3 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000214719.7 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000214773.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000215190.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000215256.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000215498.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000215498.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000215808.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000215866.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000220161.4 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000222043.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000223356.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000223374.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000223466.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000223576.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000223653.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000223685.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000223692.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000223704.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000223725.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000223745.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000223759.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000223774.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000223779.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000223784.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000223812.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000223855.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000223855.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000223960.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000223979.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000224020.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000224031.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000224034.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000224081.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000224164.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000224165.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000224167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000224189.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000224216.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000224216.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000224356.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000224356.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000224424.7 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000224574.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000224596.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000224635.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000224635.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000224687.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000224733.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000224844.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000224846.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000224905.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000224905.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000224939.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000224950.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000224972.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000225032.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000225138.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000225163.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000225187.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000225195.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000225206.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000225335.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000225335.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000225353.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000225361.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000225393.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000225470.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000225493.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000225521.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000225643.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000225703.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000225725.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000225760.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000225836.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000225839.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000225913.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000225914.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000225914.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000225963.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000225981.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000226009.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000226031.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000226067.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000226087.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000226263.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000226310.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000226352.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000226352.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000226352.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000226377.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000226419.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000226455.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000226604.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000226659.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000226661.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000226711.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000226746.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000226746.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000226752.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000226862.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000226900.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000226904.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000226913.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000226917.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000226920.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000226950.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000226954.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000227017.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000227036.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000227050.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000227071.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000227297.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000227431.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000227456.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000227477.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000227482.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000227496.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000227502.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000227512.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000227516.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000227543.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000227598.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000227617.4 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000227676.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000227678.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000227698.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000227706.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000227888.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000227896.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000227906.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000227945.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000228037.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000228065.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000228084.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000228084.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000228108.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000228109.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000228126.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000228204.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000228223.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000228237.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000228302.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000228327.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000228369.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000228386.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000228412.2 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000228420.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000228444.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000228486.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000228509.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000228509.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000228544.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000228544.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000228624.3 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000228629.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000228661.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000228661.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000228784.3 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000228798.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000228857.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000228886.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000229111.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000229124.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000229153.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000229154.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000229162.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000229178.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000229267.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000229291.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000229291.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000229327.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000229356.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000229368.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000229431.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000229645.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000229656.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000229672.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000229702.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000229728.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000229780.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000229801.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000229832.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000229869.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000229951.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000229953.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000229999.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000230063.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000230074.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000230289.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000230400.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000230410.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000230427.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000230499.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000230530.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000230537.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000230552.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000230615.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000230751.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000230815.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000230850.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000230896.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000230899.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000230910.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000230914.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000230925.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000231010.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000231054.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000231073.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000231073.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000231081.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000231128.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000231134.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000231185.2 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000231187.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000231188.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000231196.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000231290.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000231298.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000231336.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000231412.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000231439.3 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000231473.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000231536.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000231563.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000231566.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000231595.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000231611.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000231734.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000231770.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000231840.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000231851.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000231889.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000231908.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000231948.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000232043.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000232043.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000232098.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000232194.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000232233.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000232259.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000232274.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000232290.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000232300.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000232325.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000232354.3 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000232445.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000232453.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000232470.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000232485.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000232545.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000232564.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000232586.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000232600.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000232613.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000232642.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000232645.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000232684.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000232725.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000232732.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000232762.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000232762.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000232762.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000232860.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000232874.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000232912.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000232931.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000232936.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000232978.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000233008.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000233016.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000233029.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000233056.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000233058.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000233070.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000233077.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000233080.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000233215.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000233246.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000233360.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000233396.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000233559.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000233621.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000233651.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000233651.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000233695.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000233806.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000233818.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000233871.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000234019.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000234141.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000234230.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000234264.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000234432.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000234456.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000234509.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000234571.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000234571.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000234614.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000234630.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000234678.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000234705.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000234779.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000234789.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000234793.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000234817.2 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000234869.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000234902.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000234913.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000234915.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000234943.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000234945.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000235010.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000235078.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000235079.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000235138.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000235189.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000235209.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000235271.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000235298.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000235387.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000235397.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000235445.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000235481.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000235565.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000235629.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000235652.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000235660.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000235770.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000235795.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000235806.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000235823.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000235837.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000235890.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000235897.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000235999.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000235999.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000236003.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000236008.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000236016.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000236017.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000236017.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000236028.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000236088.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000236098.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000236199.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000236212.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000236255.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000236308.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000236345.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000236364.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000236510.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000236526.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000236540.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000236540.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000236545.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000236548.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000236591.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000236700.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000236799.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000236830.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000236842.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000236850.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000236871.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000236896.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000236915.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000237073.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000237188.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000237222.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000237301.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000237328.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000237336.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000237343.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000237357.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000237416.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000237471.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000237476.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000237481.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000237485.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000237489.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000237517.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000237523.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000237646.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000237686.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000237697.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000237768.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000237772.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000237813.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000237845.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000237886.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000237976.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000238005.2 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000238123.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000238178.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000238280.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000239335.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000239445.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000239480.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000239498.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000239608.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000239705.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000239774.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000240350.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000240373.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000240401.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000240440.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000240453.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000240476.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000240476.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000240497.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000240553.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000240567.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000240571.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000240661.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000240710.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000240859.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000240990.5 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000241211.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000241269.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000241280.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000241359.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000241560.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000241570.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000241732.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000241818.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000241985.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000242042.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000242125.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000242125.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000242190.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000242207.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000242282.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000242396.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000242428.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000243069.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000243176.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000243243.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000243350.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000243415.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000243433.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000243485.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000244063.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000244124.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000244198.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000244203.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000244332.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000244393.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000244393.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000244459.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000244479.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000244479.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000244479.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000244649.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000244968.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000244968.2 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000245149.3 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000245248.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000245293.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000245552.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000245711.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000245748.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000245857.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000245975.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000246334.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000246422.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000246731.2 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000246777.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000246792.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000246792.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000246982.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000247092.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000247311.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000247363.2 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000247400.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000247679.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000247735.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000247809.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000247877.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000248132.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000248161.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000248175.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000248221.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000248223.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000248223.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000248243.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000248243.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000248468.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000248668.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000248677.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000248698.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000248787.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000248846.2 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000248858.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000248932.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000248980.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000248996.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000249216.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000249249.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000249307.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000249348.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000249395.2 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000249413.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000249476.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000249509.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000249602.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000249628.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000249628.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000249635.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000249655.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000249664.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000249673.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000249684.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000249685.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000249859.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000249896.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000250027.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000250069.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000250072.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000250075.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000250081.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000250222.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000250280.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000250282.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000250286.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000250295.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000250303.2 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000250362.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000250432.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000250451.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000250584.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000250602.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000250608.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000250734.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000250742.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000250930.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000250948.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000250999.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000251003.3 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000251009.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000251009.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000251018.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000251023.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000251031.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000251093.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000251175.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000251221.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000251230.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000251273.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000251307.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000251330.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000251331.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000251359.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000251359.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000251442.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000251448.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000251555.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000251580.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000251600.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000251615.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000251661.3 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000253121.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000253187.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000253372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000253374.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000253374.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000253399.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000253399.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000253406.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000253476.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000253477.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000253522.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000253532.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000253659.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000253661.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000253666.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000253737.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000253741.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000253796.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000253802.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000253819.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000253837.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000253859.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000253898.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000253931.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000253948.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000253973.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000254003.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000254006.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000254031.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000254094.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000254099.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000254099.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000254141.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000254231.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000254248.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000254317.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000254396.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000254414.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000254444.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000254551.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000254574.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000254615.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000254620.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000254638.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000254639.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000254653.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000254694.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000254718.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000254739.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000254739.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000254762.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000254802.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000254839.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000254847.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000254854.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000254855.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000254860.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000254887.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000254900.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000254910.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000254910.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000254985.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000255008.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000255045.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000255100.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000255142.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000255153.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000255229.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000255236.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000255237.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000255248.2 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000255276.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000255320.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000255328.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000255449.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000255456.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000255487.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000255520.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000255521.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000255557.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000255559.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000255621.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000255650.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000255672.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000255750.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000255808.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000255989.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000256006.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000256092.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000256151.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000256234.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000256433.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000256442.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000256448.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000256481.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000256542.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000256564.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000256596.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000256746.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000256789.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000256916.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000256943.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000256947.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000256967.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000257004.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000257027.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000257027.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000257058.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000257058.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000257139.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000257151.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000257176.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000257183.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000257193.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000257261.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000257272.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000257285.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000257433.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000257496.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000257496.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000257497.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000257507.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000257588.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000257595.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000257647.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000257910.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000257964.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000258010.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000258082.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000258086.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000258301.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000258302.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000258323.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000258323.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000258325.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000258334.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000258457.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000258499.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000258535.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000258731.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000258731.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000258735.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000258752.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000258789.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000258807.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000258813.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000258857.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000258903.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000258927.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000258942.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000258955.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000258959.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000259031.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000259070.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000259129.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000259172.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000259182.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000259187.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000259212.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000259238.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000259244.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000259254.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000259274.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000259343.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000259345.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000259349.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000259416.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000259424.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000259438.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000259448.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000259456.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000259488.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000259523.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000259584.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000259606.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000259644.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000259687.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000259705.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000259705.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000259709.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000259717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000259723.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000259727.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000259732.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000259755.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000259758.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000259775.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000259796.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000259935.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000259953.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000260000.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000260015.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000260021.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000260034.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000260035.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000260060.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000260095.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000260132.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000260136.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000260167.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000260167.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000260177.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000260196.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000260198.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000260231.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000260252.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000260260.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000260269.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000260273.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000260285.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000260288.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000260296.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000260317.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000260328.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000260352.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000260367.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000260369.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000260398.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000260470.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000260517.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000260558.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000260589.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000260591.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000260601.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000260608.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000260630.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000260646.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000260648.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000260651.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000260664.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000260671.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000260671.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000260735.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000260757.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000260792.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000260834.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000260871.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000260871.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000260877.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000260907.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000260910.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000260912.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000260924.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000260927.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000260938.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000260942.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000260949.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000260953.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000260973.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000260988.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000261068.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000261069.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000261168.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000261173.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000261200.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000261211.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000261216.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000261253.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000261314.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000261318.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000261369.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000261386.2 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000261386.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000261416.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000261420.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000261447.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000261471.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000261476.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000261485.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000261488.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000261570.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000261616.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000261644.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000261697.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000261713.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000261761.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000261770.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000261770.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000261773.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000261773.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000261783.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000261838.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000261889.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000261925.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000261996.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000262089.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000262115.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000262115.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000262115.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000262136.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000262152.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000262188.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000262228.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000262265.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000262298.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000262319.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000262339.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000262370.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000262434.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000262454.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000262514.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000262585.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000262652.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000262686.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000262745.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000262766.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000262769.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000262903.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000262951.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000263050.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000263280.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000263307.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000263400.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000263477.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000263644.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000263680.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000263753.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000263859.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000263862.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000263884.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000263975.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000264043.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000264043.2 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000264167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000264188.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000264207.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000264365.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000264448.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000264575.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000264630.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000264635.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000264808.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000264829.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000264954.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000264964.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000265010.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000265091.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000265094.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000265130.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000265185.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000265222.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000265479.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000265656.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000265717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000265743.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000265749.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000265845.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000265908.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000266010.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000266040.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000266236.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000266256.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000266290.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000266311.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000266397.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000266402.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000266445.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000266445.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000266466.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000266469.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000266498.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000266644.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000266651.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000266717.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000266767.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000266824.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000266824.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000266844.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000266895.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000266933.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000266957.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000266975.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000266983.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000266993.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000267003.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000267025.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000267058.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000267063.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000267064.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000267065.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000267079.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000267082.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000267104.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000267108.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000267128.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000267150.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000267169.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000267193.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000267201.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000267207.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000267213.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000267230.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000267255.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000267268.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000267280.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000267298.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000267302.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000267302.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000267366.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000267390.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000267446.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000267481.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000267481.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000267491.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000267504.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000267547.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000267557.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000267565.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000267568.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000267583.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000267651.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000267651.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000267701.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000267737.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000267747.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000267758.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000267786.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000267871.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000268027.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000268027.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000268061.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000268119.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000268307.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000268307.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000268340.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000268401.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000268516.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000268549.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000268549.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000268583.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000268621.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000268658.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000268686.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000268707.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000268751.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000268913.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000268913.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000268938.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000269290.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000269397.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000269481.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000269534.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000269560.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000269640.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000269680.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000269688.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000269688.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000269694.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000269836.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000269888.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000269894.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000269903.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000269906.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000269910.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000269923.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000269923.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000269925.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000269925.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000269938.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000269938.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000269940.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000269951.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000269951.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000269956.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000269959.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000269967.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000269967.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000269971.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000269976.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000269980.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000269997.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000269997.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000270001.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000270006.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000270010.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000270012.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000270038.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000270048.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000270061.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000270083.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000270095.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000270095.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000270097.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000270103.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000270109.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000270117.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000270127.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000270133.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000270140.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000270141.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000270154.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000270157.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000270177.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000270190.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000270210.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000270344.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000270482.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000270571.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000270580.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000270659.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000270720.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000270720.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000270720.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000270742.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000270933.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000270949.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000270951.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000271109.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000271109.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000271127.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000271147.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000271218.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000271335.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000271344.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000271398.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000271401.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000271551.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000271590.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000271631.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000271659.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000271734.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000271738.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000271751.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000271778.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000271778.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000271781.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000271782.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000271851.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000271857.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000271871.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000271882.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000271914.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000271943.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000271947.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000271964.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000271992.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000271993.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000272004.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000272068.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000272076.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000272081.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000272109.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000272137.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000272168.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000272172.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000272198.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000272198.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000272209.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000272209.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000272221.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000272225.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000272250.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000272250.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000272255.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000272263.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000272265.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000272288.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000272312.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000272335.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000272338.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000272342.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000272361.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000272366.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000272370.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000272379.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000272482.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000272505.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000272520.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000272524.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000272525.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000272574.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000272659.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000272666.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000272668.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000272690.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| JNK-9L |
ENSG00000272699.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000272716.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000272754.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000272755.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000272763.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000272764.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000272764.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000272764.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000272769.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000272795.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000272824.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000272859.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000272862.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000272864.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000272870.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000272871.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000272872.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000272892.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000272894.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000272913.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000272917.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000272917.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000272933.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000272940.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000272989.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000273002.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000273007.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000273008.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000273035.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000273038.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000273038.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000273073.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000273084.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000273117.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000273125.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000273156.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000273160.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000273164.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000273174.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000273188.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000273216.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000273245.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| JNK-9L |
ENSG00000273249.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000273289.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000273308.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000273335.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000273338.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000273343.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| JNK-9L |
ENSG00000273343.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| JNK-9L |
ENSG00000273353.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000273353.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| JNK-9L |
ENSG00000273365.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000273399.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000273416.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| JNK-9L |
ENSG00000273437.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000273448.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| JNK-9L |
ENSG00000273449.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| JNK-9L |
ENSG00000273449.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000273451.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| JNK-9L |
ENSG00000273472.1 |
Predicted lncRNA |
Sarcoma |
|
| JNK-9L |
ENSG00000273476.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| JNK-9L |
ENSG00000273486.1 |
Predicted lncRNA |
Esophageal cancer |
|
| JNK-9L |
ENSG00000273487.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
